Search Publications

Search

per page

Found 457 matches. Displaying 1 - 10

[ 1 - 10 | Next ]

1. Han G, Armstrong A, Krueger JG, Jacobson A   IL-17C as a Driver of Inflammation in Psoriasis   ADVANCES IN THERAPY 2025 NOV; 42(11):5451-5467 Full Text | PMID/PMCID

2. Warren RB, Weiss A, Felding J, Sommer MOA, Garcet S, Krueger JG   Orismilast, a Potent and Selective PDE4B/D Inhibitor, Reduces Protein Levels of Key Disease Driving Cytokines in the Skin of Patients With Plaque Psoriasis   EXPERIMENTAL DERMATOLOGY 2025 SEP 19; 34(9):? Article e70153 Full Text | PMID/PMCID

3. Imanishi I, Gill R, Wilder A, Restrepo P, Nair A, Cho IC, Krueger JG, Guttman-Yassky E, Kim BS, Ji AL   A basophil-fibroblast pro-inflammatory axis fuels type 2 skin inflammation   CELL REPORTS 2025 AUG 26; 44(8):? Article 116114 Full Text | PMID/PMCID

4. Kim J, Lee J, Lee J, Kim K, Li X, Zhou W, Cao J, Krueger JG   Psoriasis harbors multiple pathogenic type 17 T-cell subsets: Selective modulation by risankizumab   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 2025 JUN; 155(6):? Full Text | PMID/PMCID

5. Sachen KL, Hammaker D, Sarabia I, Stoveken B, Hartman J, Leppard KL, Manieri NA, Bao PC, Greving C, Lacy ER, Duprie M, Wertheimer J, Deming JD, Brown J, Hart A, Li H, Freeman TC, Keyes B, Kohler K, White I, Karpowich N, Steele R, Elloso MM, Fakharzadeh S, Goyal K   Guselkumab binding to CD64<SUP>+</SUP> IL-23-producing myeloid cells enhances potency for neutralizing IL-23 signaling   FRONTIERS IN IMMUNOLOGY 2025 MAR 12; 16(?):? Article 1532852 Full Text | PMID/PMCID

6. Farag A, Visvanathan S, Bachelez H, Morita A, Lebwohl MG, Barker JN, Choon SE, Burden AD, Tsai TF, Leparc G, Delic D, Lang B, Thoma C, Krueger JG   Spesolimab Reduces Inflammation in Generalized Pustular Psoriasis: Molecular Characterization of Flare Treatment in EFFISAYIL 1   JOURNAL OF INVESTIGATIVE DERMATOLOGY 2025 MAR; 145(3):? Full Text | PMID/PMCID

7. Shishido-Takahashi N, Garcet S, Cueto I, Miura S, Li X, Rambhia D, Kunjravia N, Hur HB, Lee YI, Ham S, Anis N, Kim J, Krueger JG   Hepatocyte Growth Factor Has Unique Functions in Keratinocytes that Differ from those of IL-17A and TNF and May Contribute to Inflammatory Pathways in Hidradenitis   JOURNAL OF INVESTIGATIVE DERMATOLOGY 2025 MAR; 145(3):? Full Text | PMID/PMCID

8. Jeong S, Joh CSY, Lee S, Krueger JG, Chae JH, Kim HJ, Jo SJ   Single-cell transcriptomic analysis of GPP patients treated with IL-12/23 or IL-17A blockade   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 2025 2025 MAR 25; ?(?):? Full Text | PMID/PMCID

9. Strober B, Boehncke WH, Krueger JG, Magnolo N, Vender R, Warren RB, Pinto JML, Kavanagh S, Hoepken B, Gisondi P   Bimekizumab Efficacy in Psoriasis by Subgroups: Post Hoc Analysis of Phase 3/3b Clinical Trials   DERMATOLOGY AND THERAPY 2025 2025 OCT 8; ?(?):? Full Text | PMID/PMCID

10. Gold LS, Gottlieb AB, Armstrong AW, Alkousakis T, Bissonnette R, Langley RG, Krueger J, Papp K, Choi O, Rowland K, Chan DP, Jeyarajah J, Park-Wyllie L, Gao LL, Gordon KB, Merola JF, Lebwohl MG, Strober B   SPECTREM phase IIIb clinical trial results through week 16: guselkumab efficacy and safety for the treatment of low body surface area, moderate psoriasis with high-impact site involvement   BRITISH JOURNAL OF DERMATOLOGY 2025 2025 OCT 29; ?(?):? Full Text | PMID/PMCID

[ 1 - 10 | Next ]